Comparing two types of dressings for preventing pressure ulcers in cardiac surgery patients
Effectiveness of Polyurethane Foam (Pink Pad) Compared With Mepilex Dressing for Pressure Ulcer Prevention in Operating Room: A Randomized Control Clinical Trial
This study is testing which type of dressing, either polyurethane foam or Mepilex, works better to prevent pressure ulcers in patients having heart surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | King Abdullah Medical City Government |
| Locations | 1 site (Mecca, Western Reagan) |
| Trial ID | NCT06790277 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of polyurethane foam (Pink Pad) and Mepilex dressings in preventing pressure ulcers in patients undergoing cardiac surgery at King Abdullah Medical City. Both interventions will be applied in conjunction with standard care protocols, which include risk assessment using the Braden Scale. The study will evaluate the outcomes of each dressing type in terms of pressure ulcer prevention during surgical procedures. Participants will be monitored for their skin integrity and overall health status post-surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are undergoing cardiac surgery and are at risk for pressure ulcer development.
Not a fit: Patients under 17 years old or those with hypersensitivity to the dressing materials may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved methods for preventing pressure ulcers in patients undergoing cardiac surgery.
How similar studies have performed: Previous studies have shown success in using similar dressing approaches for pressure ulcer prevention, indicating potential for positive outcomes in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects ≥ 18. * Willing to participate. * Patients undergoing cardiac surgery. * Patient who is at risk for PU development as measured with Braden scale. * Patient who has skin intact and having a life expectancy greater than 72 hours as per clinical judgement. Exclusion Criteria: * Subjects under 17 * Not consenting to participate * Patients with suspected hypersensitivity reactions to any of the dressing formulation's ingredients. * Patients who are unable to continue the study because of death or change in the care setting.
Where this trial is running
Mecca, Western Reagan
- King Abdulla Medical City in Holy capital — Mecca, Western Reagan, Saudi Arabia (Recruiting)
Study contacts
- Study coordinator: Wedian O. Almowallad / Head of Clinical Trial Department, Master
- Email: Almwlld.W@kamc.med.sa
- Phone: 012 5549999
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.